Clinical trial
Egulation of Endogenous Glucose Production by Brain Insulin Action in Insulin Resistance
NCT03383822 is registered in ClinicalTrials.gov with University Health Network, Toronto as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Egulation of Endogenous Glucose Production by Brain Insulin Action in Insulin Resistance
- Lead sponsor
- University Health Network, Toronto
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- September 8, 2015
- Completion date
- December 1, 2017
- Enrollment
- 7 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.